Flu Treatments: What's New and What's for You
During last year’s bad flu season, so many people were trying to get Tamiflu that some areas had shortages. (Source: WebMD Health)
Source: WebMD Health - November 27, 2018 Category: Consumer Health News Source Type: news

Personal Health: Need a Flu Shot? Get It Now
Immunity tends to wane by 20 percent a month, leaving those who got their shot in August or September with less than desirable protection by the time they ’ re exposed. (Source: NYT Health)
Source: NYT Health - November 5, 2018 Category: Consumer Health News Authors: JANE E. BRODY Tags: Influenza Vaccination and Immunization Tamiflu (Drug) Relenza (Drug) Viruses Epidemics Source Type: news

The New Anti-Flu Drug Xofluza's Value Proposition
An improved clinical benefit profile together with the potential for diminished physician service and hospital spending appear to justify the Xofluza ' s price premium relative to Tamiflu. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 1, 2018 Category: Pharmaceuticals Authors: Joshua Cohen, Contributor Source Type: news

F.D.A. Approves New Drug for Flu
The new drug, sold as Xofluza, is about as effective as Tamiflu in shortening flu symptoms, and is expected to work against drug-resistant strains. (Source: NYT Health)
Source: NYT Health - October 24, 2018 Category: Consumer Health News Authors: DONALD G. McNEIL Jr. Tags: Influenza Drugs (Pharmaceuticals) Tamiflu (Drug) Gottlieb, Scott (1972- ) Genentech Inc Shionogi Xofluza Source Type: news

The FDA Approved a New Flu Treatment, Just In Time for Flu Season
The Food and Drug Administration (FDA) has approved a new antiviral influenza treatment. The agency on Wednesday approved Genentech’s drug Xofluza, which can be taken via a single oral dose to help patients recover more quickly from the flu. It’s the “first new antiviral flu treatment with a novel mechanism of action approved by the FDA in nearly 20 years,” FDA Commissioner Dr. Scott Gottlieb said in a statement. The main factor differentiating Xofluza from other antiviral flu treatments on the market, such as Tamiflu and Relenza, is the way it’s taken. Xofluza is the only antiviral that can b...
Source: TIME: Health - October 24, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Drugs healthytime onetime Source Type: news

FDA Approves First-in-Class Flu Drug
(MedPage Today) -- Baloxavir at least as effective as oseltamivir (Tamiflu) in clinical trials, with different mechanism (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - October 24, 2018 Category: American Health Source Type: news

Here ’s How to Tell if You Have a Cold or the Flu
Your nose is dripping like a leaky faucet, your throat is sore and you can’t stop sneezing. You don’t have a fever, but you feel wiped out—like you could curl up on the floor and fall asleep. Do you have a cold or the flu? If you guessed cold, you’re probably right. But experts say that differentiating the common cold (an upper respiratory infection) from the flu (influenza) can be trickier than most people assume. “There is huge overlap among non-influenza viruses and the symptoms produced by influenza and other bugs,” says Dr. Bruce Barrett, a professor of family medicine and community...
Source: TIME: Health - October 11, 2018 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized public health Source Type: news

More Evidence That Baloxavir Reduces Flu Symptom Duration
(MedPage Today) -- Investigational antiviral matches or exceeds efficacy of oseltamivir (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - October 8, 2018 Category: Infectious Diseases Source Type: news

New Flu Drug Cuts Time to Recovery New Flu Drug Cuts Time to Recovery
The single-dose agent is safe and effective and has a shorter viral shedding time than oseltamivir, according to results from CAPSTONE 2, which could play a role in the drug ' s approval by year end.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 7, 2018 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

New One-Dose Flu Drug Shows Promise
The study also found it as effective as the current standard drug, oseltamivir (Tamiflu), at controlling symptoms such as coughing, sore throat, headache, fever, muscle and joint pain, and fatigue. (Source: WebMD Health)
Source: WebMD Health - September 6, 2018 Category: Consumer Health News Source Type: news

Baloxavir Reduces Flu Symptoms and Viral Shedding Baloxavir Reduces Flu Symptoms and Viral Shedding
The first-in-class antiviral drug reduced duration of influenza symptoms and viral shedding compared with both placebo and oseltamivir in phase 2 and phase 3 randomized trials.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 5, 2018 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Baloxavir Cuts Median Length of Flu Symptoms
(MedPage Today) -- But relief no faster than with Tamiflu (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - September 5, 2018 Category: Infectious Diseases Source Type: news

Roche Touts New Flu Drug as Tamiflu Suffers Generics Hit Roche Touts New Flu Drug as Tamiflu Suffers Generics Hit
Swiss drugmaker Roche ' s hopes of recapturing lost ground in the generics-flooded influenza market got a boost after a late-stage study showed its new medicine reduced symptoms in people at high risk of complications.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 18, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Roche single-dose flu med finds success for people at high risk of complications
Baloxavir marboxil, the company ' s Tamiflu replacement, had previously shown only modest benefits in older studies (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 17, 2018 Category: Pharmaceuticals Source Type: news

Roche touts new flu drug as Tamiflu suffers generics hit
Swiss drugmaker Roche's hopes of recapturing lost ground in the generics-flooded influenza market got a boost after a late-stage study showed its new medicine reduced symptoms in people at high risk of complications. (Source: Reuters: Health)
Source: Reuters: Health - July 17, 2018 Category: Consumer Health News Tags: healthNews Source Type: news